Commercial blot assays in the diagnosis of systemic rheumatic diseases
- 31 July 2009
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 8 (8), 645-649
- https://doi.org/10.1016/j.autrev.2009.02.012
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The laboratory approach to the diagnosis of autoimmune diseases: Is it time to change?Autoimmunity Reviews, 2007
- Recent advances in diagnostic technologies and their impact in autoimmune diseasesAutoimmunity Reviews, 2007
- Technology Insight: can autoantibody profiling improve clinical practice?Nature Clinical Practice Rheumatology, 2007
- Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patientsSeminars in Arthritis and Rheumatism, 2004
- Autoantibodies as predictors of diseaseThe Lancet, 2004
- Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodiesAnnals Of The Rheumatic Diseases, 2000
- Autoantibodies in the diagnosis of systemicrheumatic diseasesSeminars in Arthritis and Rheumatism, 1995
- Immunoblotting and dot blottingJournal of Immunological Methods, 1989
- Immunoblotting and dot immunobinding — Current status and outlookJournal of Immunological Methods, 1984
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences of the United States of America, 1979